A Louisville-based at-home wound care provider has agreed to pay more than $2.6 million to settle federal allegations that it overbilled Medicare and TRICARE for costly skin substitute products used to treat chronic and acute wounds. Heuser Health, run by Louis Heuser and Peggy Heuser, reached the settlement as part of a broader federal crackdown known as Operation Skin Scam, which targets fraud schemes tied to expensive skin substitute materials.
According to the Lexington Herald-Leader, the United States alleged that Heuser Health submitted claims using invoice amounts higher than its true purchase prices, which led to inflated reimbursements paid out by Medicare and TRICARE. Federal rules required Heuser Health to bill its products based on invoice price, since skin substitutes without an established Average Sales Price must be billed at net invoice cost after accounting for discounts, rebates, and other adjustments, according to Noridian Medicare. Skin substitutes are bioengineered or tissue-derived materials used to replace, imitate, or regenerate damaged skin, and Medicare covers those deemed reasonable and necessary. Louis and Peggy Heuser did not respond to requests for comment prior to publication of the Herald-Leader's report.
A Federal Task Force Zeroes In On Wound Care Billing
The federal investigation into Heuser Health was led by Assistant U.S. Attorneys Matt Weyand and Jessica R. C. Malloy, along with U.S. Attorney's Office Auditor Phil Bezehertny in the Western District of Kentucky, according to the Department of Justice. Kyle G. Bumgarner said the settlement reflects a commitment to enforcing federal billing rules and protecting Medicare and TRICARE from abuse, adding that seeking reimbursement beyond entitlement undermines the integrity of those programs and misuses taxpayer funds. Healthcare providers, Bumgarner said, must bill federal healthcare programs accurately and transparently.
Operation Skin Scam is part of the Trump administration's broader effort to crack down on potentially fraudulent Medicare and Medicaid claims. A task force and the Department of Justice reported in July that Medicare skin substitute claims had increased by 7,100% over the preceding six years, a surge that regulators say fueled the push for tighter oversight. Skin substitute payments can range from approximately $100 to more than $1,000 per square centimeter, according to figures cited from HHS and its Office of Inspector General, with insurance payments based on the number of service units billed.
National Spending Surge Behind the Crackdown
The Heuser Health case fits into a much larger pattern of federal scrutiny. An HHS Office of Inspector General report found that annual Medicare Part B expenditures for skin substitutes ballooned from $400 million per quarter in 2022 to more than $10 billion annually by the end of 2024. The same report found that Medicare enrollees receiving skin substitutes in home-based settings, like those served by Heuser Health, incurred billing costs four times higher than patients treated in traditional medical offices.
Separate data compiled by PICA shows that between 2019 and 2024, the number of Medicare beneficiaries treated with skin substitute products doubled, while overall Medicare Part B non-facility spending on the products jumped 40-fold, from $250 million to more than $10 billion. Compliance analysts at Benesch Law have identified red flags common in skin substitute billing schemes, including “stacking” claims to dodge the $99,999.99 single-claim payment cap and billing for advanced grafts without first providing required conservative wound care.
Regulators Respond With a New Payment Cap
In response to the spending surge, the Centers for Medicare and Medicaid Services overhauled reimbursement rules effective January 1, replacing the old invoice-spread billing model with a standardized flat rate ceiling of approximately $127 per square centimeter under the CY2026 Physician Fee Schedule, according to a report from BGR Group. The policy change was projected to cut Part B spending on skin substitutes by nearly $9.4 billion.
The Heuser Health settlement arrives alongside a wave of similar enforcement actions nationwide. In May, a federal grand jury in Utah indicted a podiatrist and two nurses for allegedly submitting $44 million in fraudulent skin substitute claims to Medicare without providing required initial conservative care, as reported by Becker's ASC Review. And in April, federal agents seized more than $2 million from a Pasadena wound care clinic that had billed Medicare $46.6 million for skin substitute grafts, averaging $37,449 per claim, more than double the national average, as Hoodline previously reported. Unlike those criminal cases, the Heuser Health settlement resolves civil False Claims Act allegations without any determination of liability.
